(January 15, 2020) A new study in the Journal of the American Medical Association (JAMA) found no statistically significant association between self-reported use of powder in the genital area and subsequent risk of developing ovarian cancer. Published earlier this month, the study used a pooled analysis of 4 large US cohorts, including 252,745 women with … Continued
(January 13, 2020) Thanks to your support, 22 top scientists at 19 eminent medical centers across the world will delve into important topics across the ovarian cancer landscape. In 2020, along with our other ongoing grants and programs, OCRA is investing nearly $9 million in the fight against ovarian cancer. These grants, awarded internationally for … Continued
(January 6, 2020) For the past 14 years, OCRA has hosted Turn Up the Heat: Celebrating Female Superstars, a fabulous foodie fest packed full of tantalizing treats and eats from the most exciting female chefs, mixologists and restaurateurs, all for a good cause. And it is with profound gratitude for the opportunity to host this … Continued
(December 23, 2019) OCRA-funded scientist Dr. Sarah Gitto is making strides toward better harnessing the immune system to fight ovarian cancer. As reported recently in Gynecologic Oncology, Dr. Gitto and her colleagues at the University of Pennsylvania successfully created patient “avatars,” which mimic a patient’s biological profile based on a number of factors. Using these … Continued
WASHINGTON, D.C. – December 20, 2019 – Later today, President Trump is expected to sign into law a spending package that funds the government for the remainder of Fiscal Year (FY) 2020 and includes a significant increase in funding for the Ovarian Cancer Research Program (OCRP) at the Department of Defense (DoD). The legislation funds … Continued
(December 19, 2019) A cancer diagnosis can bring with it a bevy of complicated responses, including fear, anger, and even guilt. No one should have to navigate these tricky waters alone. Every day, OCRA’s Woman to Woman peer support programs across the country help hundreds of women diagnosed with gynecologic cancer receive the emotional support … Continued
OCRA-funded scientists have been hard at work this year, uncovering breakthroughs in ovarian cancer prevention, diagnostics, and treatment that can save women’s lives. Our grantees have made incredible progress toward better understanding and eradicating ovarian cancer. Their findings will have real-life impact for women and families battling this disease — and these stunning advancements would … Continued
It’s the season of giving, and all over the nation, OCRA Heroes are coming together to fundraise for ovarian cancer research. And they are extraordinary! I’m writing today to tell you about one of our most dedicated, vocal OCRA Heroes, Mai Linh Nguyen Achong. Mai Linh was diagnosed with ovarian cancer in 2008, when she … Continued
(December 3, 2019) The origins of high grade serous ovarian carcinoma (HGSOC) is a debated topic in the scientific community. Prior research has suggested the cancer arises from the fallopian tube epithelium, and other evidence supports the theory that ovarian surface epithelium cells are the site of origin. OCRA-funded research by Shuang Zhang, PhD, from … Continued
Friends, The day before Thanksgiving is a busy one for me, and I imagine, for you too. But before I turn my attention to holiday prep, I wanted to sit down and write this email to you, and everyone who supports OCRA. THANK YOU. It’s hard to overstate the deep gratitude I feel when I … Continued
(November 25, 2019) This Giving Tuesday, we need your help to make a big impact. For the 22,000 American women diagnosed with ovarian cancer every year, and the 200,000 living with this disease, we’re asking you to join us in #GivingTeal. Here’s how you can help. Be an OCRA Holiday Hero Spread the word and … Continued
(November 13, 2019) A study recently published in Nature Communications and led by OCRA grantee Dr. Rugang Zhang showed that the ARID1A protein plays a fundamental role in ensuring correct chromosome segregation when the cells divide. Specifically, ARID1A controls expression of another protein called STAG1 that is required to keep chromosome ends together. When ARID1A … Continued
Get email updates about research news, action alerts, and ways to join the fight.
A global, Al-powered ecosystem designed to transform gynecologic cancer research—connecting patients, researchers, and clinicians to accelerate breakthroughs.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
